Literature DB >> 17364012

Developing model language for disclosing financial interests to potential clinical research participants.

Kevin P Weinfurt1, Jennifer S Allsbrook, Joëlle Y Friedman, Michaela A Dinan, Mark A Hall, Kevin A Schulman, Jeremy Sugarman.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17364012      PMCID: PMC1825040     

Source DB:  PubMed          Journal:  IRB        ISSN: 0193-7758


× No keyword cloud information.
  11 in total

1.  Uneasy alliance--clinical investigators and the pharmaceutical industry.

Authors:  T Bodenheimer
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

2.  Is academic medicine for sale?

Authors:  M Angell
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

3.  Protecting research subjects--what must be done.

Authors:  D Shalala
Journal:  N Engl J Med       Date:  2000-09-14       Impact factor: 91.245

4.  Protecting subjects, preserving trust, promoting progress II: principles and recommendations for oversight of an institution's financial interests in human subjects research.

Authors: 
Journal:  Acad Med       Date:  2003-02       Impact factor: 6.893

Review 5.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors:  Justin E Bekelman; Yan Li; Cary P Gross
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

6.  (Almost) everything you ever wanted to know about informed consent. [Review of: Faden, RR and Beauchamp, TL. A history and theory of informed concsent. New York and Oxford: Oxford University Press, 1986].

Authors:  A M Capron
Journal:  Med Humanit Rev       Date:  1987-01

7.  Institutional academic industry relationship: results of interviews with university leaders.

Authors:  Eric G Campbell; Beverly Moy; Sandra Feibelmann; Joel S Weissman; David Blumenthal
Journal:  Account Res       Date:  2004 Apr-Jun       Impact factor: 2.622

8.  Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants.

Authors:  Kevin P Weinfurt; Michaela A Dinan; Jennifer S Allsbrook; Joëlle Y Friedman; Mark A Hall; Kevin A Schulman; Jeremy Sugarman
Journal:  Acad Med       Date:  2006-02       Impact factor: 6.893

9.  Views of potential research participants on financial conflicts of interest: barriers and opportunities for effective disclosure.

Authors:  Kevin P Weinfurt; Joëlle Y Friedman; Jennifer S Allsbrook; Michaela A Dinan; Mark A Hall; Jeremy Sugarman
Journal:  J Gen Intern Med       Date:  2006-09       Impact factor: 5.128

10.  Potential research participants' views regarding researcher and institutional financial conflicts of interest.

Authors:  S Y H Kim; R W Millard; P Nisbet; C Cox; E D Caine
Journal:  J Med Ethics       Date:  2004-02       Impact factor: 2.903

View more
  5 in total

1.  Using Cognitive Interviews to Enhance Measurement in Empirical Bioethics: Developing a Measure of the Preventive Misconception in Biomedical HIV Prevention Trials.

Authors:  Jeremy Sugarman; Damon M Seils; J Kemp Watson-Ormond; Kevin P Weinfurt
Journal:  AJOB Empir Bioeth       Date:  2015-05-01

2.  Patient reactions to confidentiality, liability, and financial aspects of informed consent in cardiology research.

Authors:  Alice K Fortune-Greeley; N Chantelle Hardy; Li Lin; Joëlle Y Friedman; Janice S Lawlor; Lawrence H Muhlbaier; Mark A Hall; Kevin A Schulman; Jeremy Sugarman; Kevin P Weinfurt
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2010-01-12

3.  Effects of disclosing financial interests on attitudes toward clinical research.

Authors:  Kevin P Weinfurt; Mark A Hall; Michaela A Dinan; Venita DePuy; Joëlle Y Friedman; Jennifer S Allsbrook; Jeremy Sugarman
Journal:  J Gen Intern Med       Date:  2008-04-02       Impact factor: 5.128

4.  Effects of disclosing financial interests on participation in medical research: a randomized vignette trial.

Authors:  Kevin P Weinfurt; Mark A Hall; Joëlle Y Friedman; Chantelle Hardy; Alice K Fortune-Greeley; Janice S Lawlor; Jennifer S Allsbrook; Li Lin; Kevin A Schulman; Jeremy Sugarman
Journal:  Am Heart J       Date:  2008-10       Impact factor: 4.749

5.  Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents.

Authors:  Kevin P Weinfurt; Damon M Seils; Janice P Tzeng; Li Lin; Kevin A Schulman; Robert M Califf
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.